
Seven organisations representing around 500 US hospitals have become the governing members of a newly established initiative aimed at reducing …

A new group, organised under the banner of the Alliance to Protect Medical Innovation, is blaming hospitals and PBM’s for …

Sanofi and Regeneron released a battery of new Phase III data on their PCSK9 inhibitor alirocumab this week, reinforcing the …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

